Cossma1611_GB

: photos: Evgeny Atamanenko, Avène, Shutterstock.com and personal care products launched in Europe that carry a dermatological-test- ed claim. In 2016, 26% of products boast this claim, up from 22% in 2014. Mintel global skin care analyst David Tyrrell explains the reasons for this trend: “Institutional distrust grows each day and consumers look to third parties to advise them on which products are safe to buy. Der- matological claims help to reassure them that a product is safe. Brands that attach a dermatologist-recom- mended claim or even work with dermatologists to develop a product will gain greater consumer interest.” A further reason for growth has been the global consumer interest in health, wellness and bene- fit-driven products. “More and more consumers are concerned about the real effectiveness of their skin care products and long- term effects on skin health, especial- ly consumers with skin conditions,” maintains Martine Butault, Interna- tional Press Relation Manager for Pierre Fabre’s Eau Thermale Avène. “Our approach to skin care is ethi- cal, rooted in a medical approach with a strong relationship with health professionals (dermatologists and pharmacists).” The company’s products are devel- oped, clinically tested and manufac- tured according to the standards set out by the pharmaceutical industry. “This is a key point of differentiation from many other cosmetic compa- nies,” states Butault, who says that their clinical trials last four to six months longer than the average der- mocosmetics line. The company dedicates 4.5% of its total revenue to R&D. The brand’s overall bestseller is Avène Thermal Spring Water Spray, GO FUTURE: COSMECEUTICALS www.cossma.com l 17 COS1611_16_Imogen.indd 17 26.10.16 23:21 COS1611_16_Imogen.indd 1726.10.1623:21

Pages Overview